Mkt Cap$2.29T+0.85%
24h Vol$51.85B
BTC Dom56.6%
ETH Dom8.8%
F&G18Extreme Fear
BTC$64,535.00+1.08% ETH$1,674.31-0.02% USDT$0.99940.00% BNB$611.32+1.03% USDC$0.99980.00% XRP$1.14-0.03% SOL$68.30+1.18% TRX$0.3178+0.46% FIGR_HELOC$1.02-1.29% HYPE$61.20+5.43% DOGE$0.0872-0.19% USDS$0.99970.00% LEO$9.71+1.47% RAIN$0.0131+0.58% ZEC$424.88+3.10% ADA$0.1701-1.49% BTC$64,535.00+1.08% ETH$1,674.31-0.02% USDT$0.99940.00% BNB$611.32+1.03% USDC$0.99980.00% XRP$1.14-0.03% SOL$68.30+1.18% TRX$0.3178+0.46% FIGR_HELOC$1.02-1.29% HYPE$61.20+5.43% DOGE$0.0872-0.19% USDS$0.99970.00% LEO$9.71+1.47% RAIN$0.0131+0.58% ZEC$424.88+3.10% ADA$0.1701-1.49%
News

NVS

Total Stories
1
Section
NVS
Why Is Avidity Biosciences Inc. (RNA) Stock Surging in Premarket Today?
Market Analysis

Why Is Avidity Biosciences Inc. (RNA) Stock Surging in Premarket Today?

Avidity Biosciences jumped 43% in premarket after Novartis revealed plans to buy the company for $72 per share in a $12 billion deal.

Tim FriesOct 27, 20253 min read